Borderlinetumoren des Ovars – ein Update

Meier W Die angemessene Behandlung von Borderlinetumoren (BOT) ist eine Herausforderung. Wichtig für die endgültige Einstufung und adäquate Therapie der zumeist als Zufallsbefunde diagnostizierten und häufig asymptomatischen BOT ist das sekundäre operative Staging. Nach Vorstellung der histologischen BOT-Subgruppen behandelt dieses Update die leitliniengerechte Behandlung von BOT und ggf. Rezidiven – auch unter dem Aspekt der Fertilitätserhaltung.

[1]  I. Timor-Tritsch,et al.  New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components , 2019, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  D. Heller,et al.  Borderline Brenner Tumor: A Review of the Literature. , 2019, Archives of pathology & laboratory medicine.

[3]  K. Matsuo,et al.  Utero-ovarian preservation and overall survival of young women with early-stage borderline ovarian tumors , 2019, Archives of Gynecology and Obstetrics.

[4]  Cameron W. Martin,et al.  Borderline Ovarian Tumors: Fifteen Years’ Experience at a Scottish Tertiary Cancer Center , 2018, International Journal of Gynecologic Cancer.

[5]  D. Gershenson.  Management of borderline ovarian tumours. , 2017, Best practice & research. Clinical obstetrics & gynaecology.

[6]  Steffen Hauptmann,et al.  Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria , 2016, Virchows Archiv.

[7]  F. Heitz,et al.  Management of borderline ovarian tumors. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  M. K. Kim,et al.  Controversies in borderline ovarian tumors , 2015, Journal of gynecologic oncology.

[9]  M. de Sousa Mendes,et al.  Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk. , 2015, European journal of cancer.

[10]  T. Fehm,et al.  Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study , 2015, British Journal of Cancer.

[11]  E. Darai,et al.  Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  T. Fehm,et al.  Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. , 2013, European journal of cancer.

[13]  P. Morice,et al.  Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. , 2013, Human reproduction update.

[14]  W. Kuehn,et al.  Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany , 2009, British Journal of Cancer.

[15]  L. Holmberg,et al.  Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer , 2008, International journal of cancer.

[16]  Yong-Man Kim,et al.  Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. , 2008, Gynecologic oncology.

[17]  P. Neven,et al.  Management of borderline ovarian neoplasms. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  K. Hillaby,et al.  Accuracy of ultrasound subjective ‘pattern recognition’ for the diagnosis of borderline ovarian tumors , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[19]  Antonio Malvasi,et al.  Conservative surgery for borderline ovarian tumors: a review. , 2006, Gynecologic oncology.

[20]  G. Acs.  Serous and mucinous borderline (low malignant potential) tumors of the ovary. , 2005, American journal of clinical pathology.

[21]  J. McKenney,et al.  Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up , 2005, The American journal of surgical pathology.

[22]  Gautam G. Rao,et al.  Surgical Staging of Ovarian Low Malignant Potential Tumors , 2004, Obstetrics and gynecology.

[23]  P. Hartge,et al.  Survival among women with borderline ovarian tumors and ovarian carcinoma , 2004, Cancer.

[24]  C. Haie-meder,et al.  Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  C. Olsen,et al.  Surgical Staging in Patients With Ovarian Tumors of Low Malignant Potential , 2002, Obstetrics and gynecology.

[26]  P. Morice,et al.  Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. , 2001, Fertility and sterility.

[27]  R. Scully.  Histological Typing of Ovarian Tumours , 1999, World Health Organization. International Histological Classification of Tumours.

[28]  C. Tropé,et al.  Management of borderline tumors of the ovary: state of the art. , 1998, Seminars in oncology.

[29]  V. Abeler,et al.  Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. , 1993, Gynecologic oncology.

[30]  Classification and Staging of Malignant Tumours in the Female Pelvis , 1971 .

[31]  Aimo Ojala.  Studies on Bilirubin in Amniotic Fluid: With Special Reference to Liver Function Tests , 1971, Acta obstetricia et gynecologica Scandinavica. Supplement.